Gilead Sciences, Inc.
Cash Flow Statement
| Line Item | FY2009 | FY2008 | FY2007 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $2.64B | $1.98B | $1.58B |
| Depreciation & Amortization | — | — | — |
| Depreciation | $64.6M | $51.7M | $36.9M |
| Amortization | $43.4M | $2.8M | — |
| Stock-Based Compensation | $180.7M | $153.4M | $184.6M |
| Net Cash from Operating Activities | $3.08B | $2.14B | $1.67B |
| Investing Activities | |||
| Capital Expenditures | $230.1M | $115.0M | $78.6M |
| Business Acquisitions | $1.25B | $10.9M | $46.4M |
| Net Cash from Investing Activities | $-2.22B | $-178.8M | $-1.30B |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | $998.5M | $1.97B | $487.5M |
| Net Cash from Financing Activities | $-1.05B | $-1.47B | $-171.0M |
| Net Change in Cash | $-186.3M | $491.2M | $152.1M |
| Free Cash Flow | $2.85B | $2.03B | $1.59B |